Calvert Investment Management’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-17,905
Closed -$491K 836
2016
Q3
$491K Sell
17,905
-1,355
-7% -$37.2K 0.02% 536
2016
Q2
$420K Hold
19,260
0.02% 545
2016
Q1
$430K Hold
19,260
0.02% 518
2015
Q4
$533K Sell
19,260
-378
-2% -$10.5K 0.02% 435
2015
Q3
$507K Hold
19,638
0.03% 352
2015
Q2
$487K Buy
19,638
+9,508
+94% +$236K 0.02% 371
2015
Q1
$255K Hold
10,130
0.02% 537
2014
Q4
$238K Buy
10,130
+257
+3% +$6.04K 0.02% 521
2014
Q3
$225K Sell
9,873
-9,212
-48% -$210K 0.02% 520
2014
Q2
$467K Buy
19,085
+468
+3% +$11.5K 0.03% 248
2014
Q1
$393K Buy
18,617
+8,814
+90% +$186K 0.03% 254
2013
Q4
$233K Hold
9,803
0.02% 309
2013
Q3
$210K Buy
+9,803
New +$210K 0.03% 302

Other funds holding QGENF

Calvert Investment Management's QGENF Position: Q4 2016 in Review

Calvert Investment Management sold out of QIAGEN NV (QGENF) in Q4 2016, closing a stake of 17,905 shares — an estimated $491K sold.

Calvert Investment Management first reported a position in QGENF in Q3 2013 and held it in 13 quarters. The position peaked at $533K in Q4 2015. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

  • Calvert Investment Management reported no remaining QIAGEN NV position as of Q4 2016 after selling out during the quarter.
  • Calvert Investment Management sold 17,905 QIAGEN NV shares in Q4 2016, an estimated $491K.
  • Calvert Investment Management first reported a position in QIAGEN NV in Q3 2013 and held it in 13 quarters.
  • Calvert Investment Management's QIAGEN NV position peaked at $533K in Q4 2015.
  • 189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on Calvert Investment Management's 13F filing for Q4 2016, filed 13 Feb 2017.